Related Experiment Videos
Experimental hyperacute rejection in pancreas allotransplants
W J Hawthorne1, A D Griffin, H Lau
1National Pancreas Transplant Unit, Westmead Hospital, Westmead NSW, Australia.
Transplantation
|August 15, 1996
Summary
Hyperacute rejection (HAR) in pancreas transplants can occur rapidly in sensitized recipients. This study demonstrates predictable signs of HAR within minutes of revascularization, highlighting the importance of cross-match testing.
Area of Science:
- Transplantation immunology
- Surgical pathology
Background:
- Hyperacute rejection (HAR) is a rapid immune response to organ transplants.
- Understanding HAR mechanisms is crucial for improving transplant success rates, particularly for pancreas allografts.
Purpose of the Study:
- To develop and validate a canine model for studying HAR in sensitized recipients of vascularized pancreas allografts.
- To test the hypothesis that pre-sensitization leads to HAR of pancreas transplants.
Main Methods:
- A sensitization protocol using intraperitoneal lymph node inoculation was employed in outbred mongrel dogs.
- Renal allografts were used to enhance sensitization, followed by vascularized pancreas allotransplantation.
- Graft biopsies and blood samples were collected at timed intervals post-revascularization to assess rejection markers.
Main Results:
- All renal and pancreas allografts exhibited classical hyperacute rejection patterns.
- Macroscopic changes including hemorrhage and congestion appeared within 4 minutes of pancreas revascularization.
- Histological analysis revealed edema, necrosis, and leukocytic infiltrate preceding graft infarction. Significant changes in white blood cell and platelet counts were observed.
Conclusions:
- Hyperacute rejection of pancreas allografts is a rapid, observable event within minutes of revascularization.
- Routine lymphocytotoxic cross-match testing is supported for all pancreas transplant recipients.
- Increased caution is advised for regraft pancreas allograft recipients due to heightened rejection risk.